153 results
Page 6 of 8
S-4
EX-10.20
2511w6vtg
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.29
53lvpe
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.32
aif xrreinpepgs17qa
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.33
ogq s53tdv8
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.31
epuj5ab0eoxtzh424
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-3.1
4tg7b b6xs
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-2.1
fko5hadim
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-2.2
14re3bpx6wame6bbg
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
aale3d00lhc760v5
24 Aug 20
Business combination disclosure
5:28pm
425
EX-2.2
ym56d59m9 6tetj9z
24 Aug 20
Business combination disclosure
5:28pm
425
EX-3.1
9cw1g
24 Aug 20
Business combination disclosure
5:28pm
8-K
EX-99.1
93f 5wpo8gc48
10 Mar 20
Proteostasis Therapeutics Reports Fourth Quarter andYear-End 2019 Financial Results
4:38pm
8-K
3aq799
17 Dec 19
Proteostasis Therapeutics Announces Positive Phase 2 Topline Results from Proprietary CFTR
8:30am
8-K
EX-99.1
ukp 2f96sf2rjd
17 Dec 19
Proteostasis Therapeutics Announces Positive Phase 2 Topline Results from Proprietary CFTR
8:30am